Cited by 144PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and CancerMuscle metabolism and nutrition

Amino Acid Signaling to MTOR Mediated by Inositol Polyphosphate Multikinase

Open access
Kim, Seyun, Kim, Sangwon F., Maag, David, Maxwell, Micah J., Resnick, Adam C., Juluri, Krishna R., Chakraborty, Anutosh, Koldobskiy, Michael A. +4 more·2011·Cell Metabolism

Abstract

mTOR complex 1 (mTORC1; mammalian target of rapamycin [mTOR] in complex with raptor) is a key regulator of protein synthesis and cell growth in response to nutrient amino acids. Here we report that inositol polyphosphate multikinase (IPMK), which possesses both inositol phosphate kinase and lipid kinase activities, regulates amino acid signaling to mTORC1. This regulation is independent of IPMK's catalytic function, instead reflecting its binding with mTOR and raptor, which maintains the mTOR-raptor association. Thus, IPMK appears to be a physiologic mTOR cofactor, serving as a determinant of mTORC1 stability and amino acid-induced mTOR signaling. Substances that block IPMK-mTORC1 binding may afford therapeutic benefit in nutrient amino acid-regulated conditions such as obesity and diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2011.01.007

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IPMK has roles in nutrient sensing, growth factor signaling, mRNA transport, and transcription regulation.

    “Initially identified in yeast and later recognized as essential for mammalian embryonic development, IPMK has transitioned from a niche interest to a focal point in studies of nutrient sensing, growth factor signaling, mRNA transport, and transcription regulation.”

    From From Obscurity to Prominence: IPMK’s Expanding Role in Cellular Signaling, Physiology, and Disease (2025) · cites this paper as [23]

    The Introduction and Results report IPMK’s role in amino-acid signaling to mTOR and its involvement in insulin-stimulated mTORC2 signaling. The Introduction identifies IPMK in yeast, and the Discussion reports that IPMK knockout mice die early in development. Our copy does not establish a role for IPMK in mRNA transport or transcription regulation; transcription appears only in cited reference titles. Page numbers are unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • IPMK functions in mRNA export, chromatin remodeling, transcription, nutrient sensing, and growth factor signaling.

    “Its diverse functions span a wide range of cellular processes, including mRNA export [17,18], chromatin remodeling [19,20], transcription [21,22], nutrient sensing [23], and growth factor signaling [15].”
  • IPMK stabilizes the mTORC1 complex and facilitates amino acid sensing in cells.

    “Kim et al. [23] were the first to demonstrate that IPMK stabilizes the mTORC1 complex and facilitates amino acid sensing in cells.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. Béchet J Grenson M Wiame JM Mutations affecting the repressibility of arginine biosynthetic enzymes in Sacchromyces cerevisiae Eur. J. Biochem 1970 12 31 39 5434281
  2. Dann SG Selvaraj A Thomas G mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer Trends Mol. Med 2007 13 252 259 17452018
  3. Dowling RJ Zakikhani M Fantus IG Pollak M Sonenberg N Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells Cancer Res 2007 67 10804 10812 18006825
  4. Dubois E Dewaste V Erneux C Messenguy F Inositol polyphosphate kinase activity of Arg82/ArgRIII is not required for the regulation of the arginine metabolism in yeast FEBS. Lett 2000 486 300 304 11119723
  5. Frederick JP Mattiske D Wofford JA Megosh LC Drake LY Chiou ST Hogan BL York JD An essential role for an inositol polyphosphate multikinase, Ipk2, in mouse embryogenesis and second messenger production Proc. Natl. Acad. Sci. USA 2005 102 8454 8459 15939867 PMC1150869
  6. Fujii M York JD A role for rat inositol polyphosphate kinases rIPK2 and rIPK1 in inositol pentakisphosphate and inositol hexakisphosphate production in rat-1 cells J. Biol. Chem 2005 280 1156 1164 15528195
  7. Gangloff YG Mueller M Dann SG Svoboda P Sticker M Spetz JF Um SH Brown EJ Cereghini S Thomas G Kozma SC Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development Mol. Cell. Biol 2004 24 9508 9516 15485918 PMC522282
  8. Guertin DA Stevens DM Thoreen CC Burds AA Kalaany NY Moffat J Brown M Fitzgerald KJ Sabatini DM Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1 Dev. Cell 2006 11 859 871 17141160
  9. Gulati P Gaspers LD Dann SG Joaquin M Nobukuni T Natt F Kozma SC Thomas AP Thomas G Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34 Cell Metab 2008 7 456 465 18460336 PMC2587347
  10. Hara K Yonezawa K Weng QP Kozlowski MT Belham C Avruch J Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism J. Biol. Chem 1998 273 14484 14494 9603962
  11. Hara K Maruki Y Long X Yoshino K Oshiro N Hidayat S Tokunaga C Avruch J Yonezawa K Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action Cell 2002 110 177 189 12150926
  12. Jacinto E Loewith R Schmidt A Lin S Rüegg MA Hall A Hall MN Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive Nat. Cell Biol 2004 6 1122 1128 15467718
  13. Kim DH Sarbassov DD Ali SM King JE Latek RR Erdjument-Bromage H Tempst P Sabatini DM mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery Cell 2002 110 163 175 12150925
  14. Krebs M Amino acid-dependent modulation of glucose metabolism in humans Eur. J. Clin. Invest 2005 35 351 354 15948894
  15. Luo HR Huang YE Chen JC Saiardi A Iijima M Ye K Huang Y Nagata E Devreotes P Snyder SH Inositol pyrophosphates mediate chemotaxis in Dictyostelium via pleckstrin homology domain-PtdIns(3,4,5)P3 interactions Cell 2003 114 559 572 13678580
  16. Murakami M Ichisaka T Maeda M Oshiro N Hara K Edenhofer F Kiyama H Yonezawa K Yamanaka S mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells Mol. Cell. Biol 2004 24 6710 6718 15254238 PMC444840
  17. Resnick AC Snowman AM Kang BN Hurt KJ Snyder SH Saiardi A Inositol polyphosphate multikinase is a nuclear PI3-kinase with transcriptional regulatory activity Proc. Natl. Acad. Sci. USA 2005 102 12783 12788 16123124 PMC1200306
  18. Saiardi A Erdjument-Bromage H Snowman AM Tempst P Snyder SH Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases Curr. Biol 1999 9 1323 1326 10574768
  19. Saiardi A Nagata E Luo HR Snowman AM Snyder SH Identification and characterization of a novel inositol hexakisphosphate kinase J. Biol. Chem 2001 276 39179 39185 11502751
  20. Saiardi A Sciambi C McCaffery JM Wendland B Snyder SH Inositol pyrophosphates regulate endocytic trafficking Proc. Natl. Acad. Sci. USA 2002 99 14206 14211 12391334 PMC137862
  21. Saiardi A Resnick AC Snowman AM Wendland B Snyder SH Inositol pyrophosphates regulate cell death and telomere length through phosphoinositide 3-kinase-related protein kinases Proc. Natl. Acad. Sci. USA 2005 102 1911 1914 15665079 PMC548528
  22. Sancak Y Peterson TR Shaul YD Lindquist RA Thoreen CC Bar-Peled L Sabatini DM The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1 Science 2008 320 1496 1501 18497260 PMC2475333
  23. Sarbassov DD Ali SM Kim DH Guertin DA Latek RR Erdjument-Bromage H Tempst P Sabatini DM Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton Curr. Biol 2004 14 1296 1302 15268862
  24. Tremblay F Krebs M Dombrowski L Brehm A Bernroider E Roth E Nowotny P Waldhäusl W Marette A Roden M Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability Diabetes 2005 54 2674 2684 16123357
  25. Um SH D'Alessio D Thomas G Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1 Cell Metab 2006 3 393 402 16753575
  26. Wullschleger S Loewith R Hall MN TOR signaling in growth and metabolism Cell 2006 124 471 484 16469695

Cited by

Sorted by citations

Authors
Kim, S., Kim, S. F., Maag, D., Maxwell, M. J., Resnick, A. C., Juluri, K. R., Chakraborty, A., Koldobskiy, M. A., Cha, S. H., Barrow, R., Snowman, A. M., & Snyder, S. H.
Affiliations
  • Johns Hopkins University (US)
  • University of Pennsylvania (US)
Corresponding author
Snyder, Solomon H.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2011-02
Volume
13
Issue
2
Pages
215-221
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2162895146
Cited by
144
References
8
Citations by year
2026: 4 · 2025: 6 · 2024: 5 · 2023: 8 · 2022: 9 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 6 · 2017: 11 · 2016: 12 · 2015: 11 · 2014: 11 · 2013: 17 · 2012: 11
FWCI
6.37
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Drug Abuse (P50DA000266, DA 00074, DA.00266, K05DA000074)
  • National Cancer Institute (R00CA134914, K99CA134914)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK084336)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Muscle metabolism and nutrition
Keywords
inositol polyphosphate multikinase, mTORC1, amino acid signaling, raptors, protein synthesis regulation, protein-protein interaction, obesity, diabetes mellitus
MeSH terms
Amino Acids, Animals, Cell Line, Fibroblasts, Humans, Mutation, Protein Binding, Signal Transduction, Phosphotransferases (Alcohol Group Acceptor), Amino Acid Substitution, Mice, Biocatalysis, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review